Fibrinogen induces alterations of endothelial cell tight junction proteins

Journal of Cellular Physiology

Volumn 221, Issue 1, 2009, Pages 195-203

  Patibandla, Phani K ^a   Tyagi, Neetu ^a   Dean, William L ^a   Tyagi, Suresh C ^a   Roberts, Andrew M ^a   Lominadze, David ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACTIN; FIBRINOGEN; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; OCCLUDIN; ALBUMINOID; ENDOTHELIN 1; MEMBRANE PROTEIN; MESSENGER RNA; PHOSPHOPROTEIN; ZONULA OCCLUDENS 1 PROTEIN; ZONULA OCCLUDENS 2 PROTEIN; ZONULA OCCLUDENS-1 PROTEIN; ZONULA OCCLUDENS-2 PROTEIN;

ANIMAL CELL; ARTICLE; CELL LEVEL; CONTROLLED STUDY; DRUG MECHANISM; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; MICROVASCULARIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; RAT; TIGHT JUNCTION; VASCULAR RESISTANCE;

RATTUS;

ALBUMINS; ANIMALS; ENDOTHELIAL CELLS; ENDOTHELIN-1; FIBRINOGEN; GENE EXPRESSION REGULATION; HUMANS; MEMBRANE PROTEINS; PHOSPHOPROTEINS; RATS; RNA, MESSENGER; TIGHT JUNCTIONS; VASCULAR RESISTANCE;

EID: 69249225653     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21845     Document Type: Article

References (51)

1. Alessi D, Cuenda A, Cohen P, Dudley D, Saltiel A. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489-27494.
2. Altieri D, Duperray A, Plescia J, Thornton G, Languino L. 1995. Structural recognition of a novel fibrinogen gamma chain sequence (117-133) by intercellular adhesion molecule-1 mediates leukocyte-endothelium interaction. J Biol Chem 270:696-699.
3. Basuroy S, Seth A, Elias B, Naren A, Rao R. 2006. MAPK interacts with occludin and mediates EGF-induced prevention of tight junction disruption by hydrogen peroxide. Biochem J 393:69-77. (Pubitemid 43049303)
4. Bourguignon L, Gilad E, Rothman K, Peyrollier K. 2005. Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression. J Biol Chem 280:11961-11972. (Pubitemid 40418513)
5. ChaeC, Lee R, Rifai N, Ridker P. 2001. Blood pressure and inflammation in apparently healthy men. Hypertension 38:399-403. (Pubitemid 34225673)
6. Chandrasekar N, Mohanam S, Lakka SS, Dinh DH, Olivero WC, Gujrati M, Rao JS. 2003. Glial cell-induced endothelial morphogenesis is inhibited by interferingwith extracellular signalregulated kinase signaling. Clin Cancer Res 9:2342-2349. (Pubitemid 36687661)
7. Cooper J,Del Vecchio P, Minnear F, Burhop K, Selig W, Garcia J, Malik A. 1987. Measurement of albumin permeability across endothelial monolayers in vitro. J Appl Physiol 62:1076-1083. (Pubitemid 17073906)
8. Danesh J, Collins R, Appleby P, Peto R. 1998. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies. JAMA 279:1477-1482. (Pubitemid 28228207)
9. Danesh J, Lewington S,Thompson SG, Lowe GD, Collins R, Kostis JB,Wilson AC, Folsom AR, WuK, Benderly M, GoldbourtU,Willeit J, Kiechl S, Yarnell JW,Sweetnam PM, Elwood PC, CushmanM, Psaty BM, Tracy RP, Tybjaerg-HansenA, Haverkate F, de Maat MP, Thompson SG, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi R, Vahtera E, Jousilahti P, Pekkanen J, D'Agostino R, Kannel WB, Wilson PW, Tofler G, Arocha-Pinango CL, Rodriguez-Larralde A, Nagy E, Mijares M, Espinosa R, Rodriquez-Roa E, Ryder E, Diez-Ewald MP, Campos G, Fernandez V, Torres E, Coll E, Marchioli R, Valagussa F, Rosengren A, Wilhelmsen L, Lappas G, Eriksson H, Cremer P, Nagel D, Curb JD, Rodriguez B, Yano K, Salonen JT, Nyyssonen K, Tuomainen TP, Hedblad B, Lind P, Loewel H, KoenigW, Meade TW, Cooper JA, De Stavola B, Knottenbelt C, Miller GJ, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Kitamura A,Naito Y, Iso H, Salomaa V, Harald K, Rasi V, Vahtera E, Jousilahti P, Palosuo T, Ducimetiere P, Amouyel P, Arveiler D, Evans AE, Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, Lamarche B, Despres JP, Dagenais GR, Tunstall-Pedoe H, Woodward M, Ben Shlomo Y, Davey SG, Palmieri V, Yeh JL, Meade TW, Rudnicka A, Knottenbelt C, Ridker P, Rodeghiero F, Tosetto A, Shepherd J, Ford I, Robertson M, Brunner E, Shipley M, Feskens EJ, Kromhout D, Fibrinogen SC. 2005. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: An individual participant meta-analysis. JAMA 294:1799-1809. (Pubitemid 41434626)
10. D'Erasmo E, Acca M, Celi F, Medici F, Palmerini T, Pisani D. 1993. Plasma fibrinogen and platelet count in stroke. J Med 24:185-191. (Pubitemid 23226708)
11. D'Souza S, Byers-Ward V, Gardiner E, Wang H, Sung S-S. 1996. Identification of an active sequence within the first immunoglobulin domain of intercellular cell adhesion molecule-1 (ICAM-1) that interacts with fibrinogen. J Biol Chem 271:24270-24277. (Pubitemid 26327416)
12. Ehringer W, Yamany S, Steier K, Farag A, Roisen F, Dozier A, Miller F. 1999. Quantitative image analysis of F-actin in endothelial cells. Microcirculation 6:291-303. (Pubitemid 129672569)
13. Ernst E, Resch K. 1993. Fibrinogen as a cardiovascular risk factor: Ameta-analysis and review of the literature. Ann Intern Med 118:956-963. (Pubitemid 23164134)
14. Favata M, HoriuchiK,Manos E, Daulerio A, StradleyD, FeeserW, Van DykD, Pitts W, Earl R, Hobbs F, Copeland R, Magolda R, Scherle P, Trzaskos J. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273:18623-18632. (Pubitemid 28334795)
15. Filep J, Sirois M, Rousseau A, Sirois P. 1991. Effects of endothelin-1 on vascular permeability in the conscious rat: Interactions with platelet-activating factor. Br J Pharmacol 104:797-804.
16. Gordon S, Lominadze D, Saari J, Lentsch A, Schuschke D. 2005. Impaired deformability of copper-deficient neutrophils. Exp Biol Med 230:543-548.
17. Horgan M, Pinheiro J, Malik A. 1991. Mechanism of endothelin-1-induced pulmonary vasoconstriction. Circ Res 69:157-164.
18. Hubbard A, RothleinR. 2000. Intercellular adhesion molecule-1 (ICAM-1) expression and cell signaling cascades. Free Rad Biol Med 28:1379-1386.
19. Humphries S. 1995. Genetic-regulation of fibrinogen. Eur Heart J 16:16-20.
20. Kerlin B, Cooley BC, Isermann BH, Hernandez I, Sood R, ZoggM, Hendrickson SB, Mosesson MW, Lord S, Weiler H. 2004. Cause-effect relation between hyperfibrinogenemia and vascular disease. Curr Opin Hematol 103:1728-1734. (Pubitemid 38268965)
21. Kolch W. 2000. Meaningful relationships: The regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J 351:289-305. (Pubitemid 30825590)
22. Kudo S, Tsuzaka M, Ikeda M, Tanishita K. 2005. Albumin permeability across endothelial monolayers under long-term shear stress. JSME Int J Ser C 48:419-442. (Pubitemid 43905503)
23. Laine GA. 1988. Microvascular changes in the heart during chronic arterial hypertension. Circ Res 62:953-960. (Pubitemid 18126061)
24. Lawson C, Ainsworth M, Yacoub M, Rose M. 1999. Ligation of ICAM-1 on endothelial cells leads to expression of VCAM-1 via a nuclear factor-{kappa}B-independent mechanism. J Immunol 162:2990-2996. (Pubitemid 29309328)
25. Lee A, Lowe G, Woodward M, Tunstall-Pedoe H. 2007. Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: The Scottish Heart Health Study. Br Heart J 69:338-342.
26. Letcher R, Chien S, Pickering T, Sealey J, Laragh J. 1981. Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration. Am J Med 70:1195-1202. (Pubitemid 11072112)
27. LincolnDW,Larsen AM, Phillips PG, BoveK. 2003. Isolation of murine aortic endothelial cells in culture and the effects of sex steroids on their growth. In Vitro Cell Dev Biol Anim 39:140-145.
28. Lominadze D, Joshua I, Schuschke D. 1998. Increased erythrocyte aggregation in spontaneously hypertensive rats. Am J Hypertens 11:784-789. (Pubitemid 28351010)
29. Lominadze D, Schuschke D, Joshua I, Dean W. 2002. Increased ability of erythrocytes to aggregate in spontaneously hypertensive rats. Clin Exp Hypertens 24:397-406. (Pubitemid 34743402)
30. Lominadze D, Saari J, Percival S, Schuschke D. 2004. Proinflammatory effects of copper deficiency on neutrophils and lung endothelial cells. Immunol Cell Biol 82:231-238. (Pubitemid 38870015)
31. Lominadze D, Tsakadze N, Sen U, Falcone J, D'Souza S. 2005. Fibrinogen- and fragment D-induced vascular constriction. Am J Physiol 288:H1257-H1264. (Pubitemid 40270032)
32. Lominadze D, Roberts A, Tyagi N, Tyagi S. 2006. Homocysteine causes cerebrovascular leakage in mice. Am J Physiol Heart Circ Physiol 290:H1206-H1213.
33. Lopez-Belmonte J, Whittle B. 1994. The involvement of endothelial dysfunction, nitric oxide and prostanoids in the rat gastric microcirculatory responses to endothelin-1. Br J Pharmacol 112:267-271. (Pubitemid 24151737)
34. Lord S. 2007. Fibrinogen and fibrin: Scaffold proteins in hemostasis. Curr Opin Hematol 14:236-241. (Pubitemid 46597609)
35. Luscinskas F, Lawler J. 1994. Integrins as dynamic regulators of vascular function. FASEB J 8:929-938. (Pubitemid 24286856)
36. Mehta D, Malik A. 2006. Signaling mechanisms regulating endothelial permeability. Physiol Rev 86:279-367. (Pubitemid 44688424)
37. Mogford J, Davis G, Meininger G. 1997. RGDN peptide interaction with endothelial alpha5beta1 integrin causes sustained endothelial-dependent vasoconstrictionto rat skeletal muscle arterioles. J Clin Invest 100:1647-1653. (Pubitemid 27425793)
38. Parving H, Jensen H, Westrup M. 1977. Increased transcapillary escape rate of albumin and IgG in essential hypertension. Scand J Clin Lab Invest 37:223-227. (Pubitemid 8387543)
39. Plow E, Haas T, Zhang L, Loftus J, Smith J. 2000. Ligand binding to integrins. J Biol Chem 275:21785-21788.
40. Qiao R, Yan W, Lum H, Malik A. 1995. Arg-Gly-Asp peptide increases endothelial hydraulic conductivity: Comparison with thrombin response. AJP: Cell Physiol 269:C110-C117.
41. Reijerkerk A, KooijG, van der Pol SMA, Khazen S,Dijkstra CD, de Vries HE. 2006. Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells. FASEB J 20:2550-2552. (Pubitemid 44953777)
42. Rivas G, Fernandez J, Minton A. 1999. Direct observation of the self-association of dilute proteins in the presence of inert macromolecules at high concentration via tracer sedimentation equilibrium: Theory, experiment, and biological significance. Biochemistry 38:9379-9388. (Pubitemid 29347262)
43. Rodman D, Stelzner T, Zamora M, Bonvallet S, Oka M, Sato K, O'Brien R, McMurtry I. 1992. Endothelin-1 increases the pulmonary microvascular pressure and causes pulmonary edema in salt solution but not blood-perfused rat lungs. J Cardiovasc Pharmacol 20:658-663.
44. Sen U, Tyagi N, Patibandla PK, Dean WL, Tyagi SC, Roberts AM, Lominadze D. 2009. Fibrinogen-induced endothelin-1 production from endothelial cells. AJP: Cell Physiol 296:C840-C847.
45. TiruppathiC,Malik A, Del Vecchio P, KeesC,Giaever I. 1992. Electrical method for detection on endothelial cell shape change in real time: Assessment of endothelial barrier function. Proc Natl Acad Sci USA 89:7919-7923.
46. Trepat X, GrabulosaM, Buscemi L, Rico F, Farre R, Navajas D. 2005. Thrombin and histamine induce stiffening of alveolar epithelial cells. J Appl Physiol 98:1567-1574. (Pubitemid 40396539)
47. Tyagi N, Moshal KS, Tyagi SC, Lominadze D. 2007. γ-Aminbuturic acid a receptor mitigates homocysteine-induced endothelial cell permeability. Endothelium 14:315-323.
48. Tyagi N, Roberts A, Dean W, Tyagi S, Lominadze D. 2008. Fibrinogen induces endothelial cell permeability. Mol Cell Biochem 307:13-22. (Pubitemid 350238642)
49. Tyagi N, Gillespie W, Vacek J, Sen U, Tyagi S, Lominadze D. 2009. Activation of GABA-A receptor ameliorates homocysteine-induced MMP-9 activation by ERK pathway. J Cell Physiol 220:257-266.
50. Vasse M, Paysant J, Soria J, Collet J, Vannier J, Soria C. 1996. Regulation of fibrinogen biosynthesis by cytokines, consequences on the vascular risk. Haemostasis 26:331-339. (Pubitemid 26417452)
51. Zhao H, Joshua I, Porter J. 2000. Microvascular responses to endothelin in deoxycorticosterone acetate-salt hypertensive rats. Am J Hypertens 13:819-826. (Pubitemid 30604121)